𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis

✍ Scribed by Samuel K. Shinjo; Rosa M. R. Pereira; Vivian A. P. Tizziani; Ari S. Radu; Maurício Levy-Neto

Publisher
Springer
Year
2007
Tongue
English
Weight
106 KB
Volume
26
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mycophenolic acid area under the curve c
Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil
✍ Noël Zahr; Laurent Arnaud; Pierre Marquet; Julien Haroche; Nathalie Costedoat-Ch 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 1 views

Objective. Mycophenolic acid (MPA) is the active metabolite of mycophenolate mofetil (MMF), which is widely used to treat systemic lupus erythematosus (SLE). In transplantation, MPA area under the plasma concentration-time curve from 0 to 12 hours (MPA AUC 0-12 ) is correlated with clinical outcome.

Is 18F-fluorodeoxyglucose positron emiss
Is 18F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in takayasu arteritis?
✍ Laurent Arnaud; Julien Haroche; Zoulikha Malek; Frédérique Archambaud; Laetitia 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB 👁 2 views

## Abstract ## Objective ^18^F‐fluorodeoxyglucose–positron emission tomography (FDG‐PET) scanning has been proposed as a new way of assessing disease activity in Takayasu arteritis (TA), but previous studies have used the nonvalidated National Institutes of Health (NIH) global activity criteria, a